NASDAQ:XOMAO XOMA (XOMAO) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free XOMAO Stock Alerts $24.99 -0.11 (-0.44%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$24.99▼$25.2050-Day Range$24.47▼$25.7052-Week Range$20.43▼$25.85Volume1,387 shsAverage Volume3,523 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield8.36%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsInsider TradesSEC FilingsShort InterestSocial Media Get XOMA alerts: Email Address Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... About XOMA Stock (NASDAQ:XOMAO)XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.Read More XOMAO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XOMAO Stock News HeadlinesMay 1, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Exelixis (EXEL), Cyclo Therapeutics (CYTH)April 29, 2024 | seekingalpha.comLigand: Buy This Pharma Royalty Aggregator To Generate Growth In Your PortfolioMay 3, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 28, 2024 | americanbankingnews.comShort Interest in XOMA Co. (NASDAQ:XOMAO) Drops By 20.8%March 8, 2024 | benzinga.comRecap: XOMA Q4 EarningsMarch 8, 2024 | finance.yahoo.comXOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023See More Headlines Receive XOMAO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/15 Dividend4/02/2024Dividend Payable4/15/2024Today5/03/2024Next Earnings (Estimated)5/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:XOMAO CUSIPN/A CIK791908 Webwww.xoma.com Phone510-204-7200FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.76 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Owen P. Hughes Jr. (Age 49)CEO & Director Comp: $193.75kMr. Thomas M. Burns (Age 50)Senior VP of Finance & CFO Comp: $759.24kMr. Brad Sitko (Age 43)Chief Investment Officer Comp: $867.08kKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAlpha Tau MedicalNASDAQ:DRTSWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWView All CompetitorsInsidersBradley SitkoBought 1,500 shares on 5/31/2023Total: $25,695.00 ($17.13/share)Bradley SitkoBought 850 shares on 5/23/2023Total: $16,150.00 ($19.00/share)Owen HughesBought 968 shares on 5/23/2023Total: $22,709.28 ($23.46/share)Bradley SitkoBought 1,000 shares on 5/19/2023Total: $19,500.00 ($19.50/share)Bradley SitkoBought 1,500 shares on 5/15/2023Total: $35,100.00 ($23.40/share)View All Insider Transactions XOMAO Stock Analysis - Frequently Asked Questions How have XOMAO shares performed in 2024? XOMA's stock was trading at $25.12 at the beginning of the year. Since then, XOMAO stock has decreased by 0.5% and is now trading at $24.9941. View the best growth stocks for 2024 here. Are investors shorting XOMA? XOMA saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,900 shares, a drop of 20.8% from the March 31st total of 2,400 shares. Based on an average daily volume of 3,200 shares, the short-interest ratio is presently 0.6 days. View XOMA's Short Interest. When is XOMA's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our XOMAO earnings forecast. How often does XOMA pay dividends? What is the dividend yield for XOMA? XOMA announced a quarterly dividend on Wednesday, February 21st. Shareholders of record on Wednesday, April 3rd will be paid a dividend of $0.5234 per share on Monday, April 15th. This represents a $2.09 annualized dividend and a dividend yield of 8.38%. The ex-dividend date of this dividend is Tuesday, April 2nd. Read our dividend analysis for XOMAO. Is XOMA a good dividend stock? XOMA (NASDAQ:XOMAO) pays an annual dividend of $2.09 per share and currently has a dividend yield of 9.00%. XOMAO has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for XOMAO. How do I buy shares of XOMA? Shares of XOMAO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:XOMAO) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
